| Literature DB >> 33633536 |
Amelia L Fryer1, Amar Abdullah1, Juliet M Taylor1, Peter J Crack1.
Abstract
Neuroinflammation driven by type-I interferons in the CNS is well established to exacerbate the progression of many CNS pathologies both acute and chronic. The role of adaptor protein Stimulator of Interferon Genes (STING) is increasingly appreciated to instigate type-I IFN-mediated neuroinflammation. As an upstream regulator of type-I IFNs, STING modulation presents a novel therapeutic opportunity to mediate inflammation in the CNS. This review will detail the current knowledge of protective and detrimental STING activity in acute and chronic CNS pathologies and the current therapeutic avenues being explored.Entities:
Keywords: STING; cGAS; central nervous system; interferon; neuroinflammation
Year: 2021 PMID: 33633536 PMCID: PMC7900568 DOI: 10.3389/fnins.2021.621501
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677